What are the treatment options for a patient with heavy menstrual bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Heavy Menstrual Bleeding

NSAIDs are the recommended first-line pharmacologic treatment for heavy menstrual bleeding, prescribed for 5-7 days during menstruation only. 1, 2

First-Line Treatment: NSAIDs

Start with NSAIDs during active bleeding days only (5-7 days per cycle). Multiple NSAIDs have demonstrated statistically significant reductions in menstrual blood loss of 20-35%, including: 1, 3, 4

  • Ibuprofen 400 mg every 4-6 hours (FDA-approved dosing for dysmenorrhea, also effective for heavy bleeding) 5
  • Mefenamic acid 1
  • Naproxen 1
  • Diclofenac sodium 1

Critical contraindication: Avoid NSAIDs entirely in women with cardiovascular disease due to increased risk of myocardial infarction and thrombosis. 1 Screen for cardiovascular risk factors before initiating NSAID therapy. 1

Never use aspirin - it does not reduce bleeding and may actually increase blood loss. 1

Essential Initial Assessment Before Treatment

Before prescribing any treatment, you must: 1, 2

  • Rule out pregnancy immediately with beta-hCG in all reproductive-age women 1, 2
  • Assess for structural causes: fibroids, polyps, adenomyosis, endometrial pathology, or malignancy 1
  • Evaluate for coagulopathies if clinically indicated - up to 20% of women with heavy menstrual bleeding have an underlying inherited bleeding disorder 1, 2
  • Check for sexually transmitted diseases, medication interactions, and new pathologic uterine conditions 2

Second-Line Treatment Options

If NSAIDs fail after 1-3 cycles, the levonorgestrel-releasing intrauterine device (LNG-IUD) is the most effective medical treatment, reducing menstrual blood loss by 71-95%. 1, 2, 6 Over time, many women experience only light menstrual bleeding or amenorrhea with the LNG-IUD. 1

Tranexamic acid is a non-hormonal alternative that reduces menstrual blood loss by approximately 80 mL per cycle (50% reduction). 1, 3, 4 However, tranexamic acid is absolutely contraindicated in women with active thromboembolic disease, history of thrombosis, or cardiovascular disease. 1

Combined oral contraceptives may reduce menstrual blood loss by approximately 50%, though evidence is limited. 4, 7

Treatment Algorithm

  1. Start with NSAIDs (5-7 days during bleeding) for all patients without cardiovascular contraindications 1, 2
  2. If bleeding persists after 1-3 cycles, consider LNG-IUD or tranexamic acid (if no thrombotic contraindications) 2, 6
  3. If medical treatment fails and bleeding remains unacceptable, refer for surgical evaluation (endometrial ablation or hysterectomy) 2, 6

Important Counseling Points

Enhanced counseling about expected bleeding patterns and reassurance that bleeding irregularities with certain treatments are generally not harmful can significantly improve treatment adherence. 8, 2 This is particularly important for hormonal treatments where irregular bleeding is common initially. 8

Common Pitfalls to Avoid

  • Do not prescribe cyclical progestogens alone - they are ineffective for ovulatory menorrhagia unless taken at high doses (10-15 mg daily for 3 weeks out of 4). 4
  • Do not exceed ibuprofen 3200 mg total daily dose 5
  • Do not continue NSAIDs beyond 5-7 days per cycle to minimize gastrointestinal and cardiovascular risks 1, 5
  • Do not assume bleeding will resolve without treatment - address the underlying issue 1

References

Guideline

Treatment of Heavy Menstrual Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Heavy Menstrual Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and treatment of menorrhagia.

Acta obstetricia et gynecologica Scandinavica, 2007

Research

Medical management of dysfunctional uterine bleeding.

Bailliere's best practice & research. Clinical obstetrics & gynaecology, 1999

Research

Oral contraceptive pills for heavy menstrual bleeding.

The Cochrane database of systematic reviews, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.